Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.20.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 1,511 $ 5,789
Restricted cash 312 312
Accounts receivable, less allowance of $3,560 and $2,531 in 2020 and 2019, respectively 4,749 8,760
Inventory 12,192 10,995
Prepaid expenses and other current assets 1,205 1,163
Total current assets 19,969 27,019
Property, plant, and equipment, net 1,017 1,193
Goodwill 2,926 2,926
Right of use asset 135 276
Other assets 484 433
Total assets 24,531 31,847
Current liabilities:    
Accounts payable 4,056 5,332
Accrued liabilities 4,079 4,744
Deferred revenue, current portion 1,982 2,237
Term loan (net of discount) 13,562 13,466
Total current liabilities 23,679 25,779
Deferred revenue 390 358
Warranty accrual 246 245
Other liabilities 1,107 1,123
Total liabilities 25,422 27,505
Commitments and contingencies — Note 11
Redeemable preferred stock:    
Preferred stock, par value $0.001 per share; 1,000 shares authorized, 70 and 70 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 3,965 3,965
Stockholders' equity:    
Common stock, par value $0.001 per share; 40,000 shares authorized, 31,582 and 31,439 shares issued and 31,537 and 31,439 outstanding as of March 31, 2020 and December 31, 2019, respectively 32 31
Additional paid-in-capital 236,384 235,594
Accumulated other comprehensive loss (719) (701)
Accumulated deficit (240,553) (234,547)
Total stockholders' (deficit) equity (4,856) 377
Total liabilities, redeemable preferred stock and stockholders' (deficit) equity $ 24,531 $ 31,847